Beta Drugs Limited · BETA
Next result 26 Oct 2026 · Q2FY27 (projected)
₹2,001.40
-0.13% on the day
Close 6 Oct 2026 · 52w ₹1,030 – ₹2,668
—scoreno read yet
±12.4%
typical move
on its results, either way
The read
no read yet
This screen reads a company each morning in the week before its result. Its next result is 26 Oct 2026 (Q2FY27, projected); the read begins about seven days before.
Until then, what its own record says is below: it moves ±12.4% on results on average and was up after ten sessions in 1 of 3.
A read is a position on a screen, not advice. The label says where the composite ranked, the tally says how often that has gone the way it pointed, and the choice is the reader's.
What its results record says
3 results · ten sessions after each · from the close before the result
Up after ten sessions
1 of 3
mean -8.3% · median -3.0%
Best point reached
+1.6%
median · as high as +2.7%
Worst point reached
-15.1%
median · as low as -25.0%
Traded 5% above
0 of 3
closed at least that far up at some point
worst point to best point
where it ended after ten sessions
This is the range each past result travelled, on closing prices. It is a description of the past, not a level for the next one, and this site gives no entry, exit or loss-limit levels.
Last 90 sessions
daily candles · adjusted for splits and bonuses · test patterns → · the outlook for the coming hours and days → · week by week: slope, patterns, next four weeks →Against the market
same 90 sessions · every line starts at 0%Beta Drugs LimitedNIFTY 50 (market)
No sector index is mapped for this company, so only the market is shown.
Around the last result · Q1FY27
ten sessions in, the result day, ten sessions out · from the close before the resultsession closed upsession closed downNIFTY 50 (market)run-up into the result
After 10 sessions
-3.0%
₹2,439.40 on 20 Jul → ₹2,365.00 on 4 Aug
On the result day
+1.6%
close on 21 Jul against the close before
Highest it traded
+2.4%
₹2,498.80 on 22 Jul · best close +1.6%
Lowest it traded
-15.0%
₹2,072.40 on 28 Jul · worst close -13.5%
Q4FY26 15 May 2026
+1.4% after 10 · high +4.0% · low -16.6%
Q3FY26 16 Feb 2026
-23.3% after 10 · high -3.5% · low -27.9%
Ten sessions after each result
share vs market · move from the close before the resultShareNIFTY 50
Results record
move from the close before each result| Quarter | Result day | Gap | T+1 | T+10 | Market T+10 | vs market | vs sector | Vol × | Result |
|---|---|---|---|---|---|---|---|---|---|
| Q1FY27 | 21 Jul 2026 | -0.1% | -5.1% | -3.0% | +1.6% | -4.6% | — | 0.8 | — |
| Q4FY26 | 15 May 2026 | -3.8% | -13.4% | +1.8% | -0.6% | +2.4% | — | 5.6 | — |
| Q3FY26 | 16 Feb 2026 | -3.5% | -18.7% | -23.3% | -2.4% | -20.9% | — | 19.0 | — |
Reported figures
₹ crore; from the exchange's XBRL filingsRevenue ₹ cr
Net profit ₹ cr
| Quarter | Period end | Revenue | YoY | PAT | YoY | Op. margin | EPS |
|---|---|---|---|---|---|---|---|
| Q1FY27 | 30 Jun 2026 | 125 | — | 16 | — | 21.8% | 14.78 |
| Q4FY26 | 31 Mar 2026 | 93 | — | 9 | — | 18.8% | 8.93 |
| Q3FY26 | 31 Dec 2025 | 87 | — | 8 | — | 19.5% | 8.40 |
Post-mortems
Every result in full →- Ran up 71% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 3% of its 52-week high.
- Volume ran 2.1x its prior month in the fortnight before.
- No read was made before this result; recorded for the base rate.
- Ran up 18% in the 30 sessions before the result — a good number had little left to reward.
- No reported figures on file for this quarter, so the result itself could not be judged.
- No read was made before this result; recorded for the base rate.
- No reported figures on file for this quarter, so the result itself could not be judged.
- Went into the result within 5% of its 52-week low.
- No read was made before this result; recorded for the base rate.